MCL1 and breast carcinoma: The poor prognosis associated with MCL1 amplification or overexpression has been described in a spectrum of cancers, including non-small cell lung cancer, breast cancer, esophageal squamous cell carcinoma, and acute myeloid leukemia, but not in glioma (49–52).